Pulmonary arterial hypertension (PAH) is a serious and life-threatening condition for which the prognosis remains poor. Treatment options include endothelial receptor antagonists, phosphodiesterase (PDE5) inhibitors and prostanoids.
Pulmonary arterial hypertension (PAH) is a serious and life-threatening condition for which the prognosis remains poor. Treatment options include endothelial receptor antagonists, phosphodiesterase (PDE5) inhibitors and prostanoids.
Therapeutic Strategies in Pulmonary Arterial Hypertension / Vizza, Carmine Dario; Badagliacca, Roberto; Poscia, Roberto; Mezzapesa, Mario; Nocioni, Martina; Fedele, Francesco. - In: EUROPEAN CARDIOLOGY. - ISSN 1758-3756. - (2012), pp. 198-203.
Therapeutic Strategies in Pulmonary Arterial Hypertension
VIZZA, Carmine Dario;BADAGLIACCA, ROBERTO;POSCIA, ROBERTO;MEZZAPESA, MARIO;NOCIONI, MARTINA;FEDELE, Francesco
2012
Abstract
Pulmonary arterial hypertension (PAH) is a serious and life-threatening condition for which the prognosis remains poor. Treatment options include endothelial receptor antagonists, phosphodiesterase (PDE5) inhibitors and prostanoids.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
